Quest Diagnostics Reports Strong Q1 2026 Earnings with Revenue Growth and Strategic Expansion
Quest Diagnostics Incorporated reported Q1 2026 earnings with revenue growth of over 9%, driven by organic demand across physician, hospital, and consumer channels. The company highlighted strong performance in advanced diagnostics and operational efficiency initiatives, with full-year guidance raised despite excluding M&A contributions.
Tickers: $DGX
Topics: Clinical Innovations Earnings Operational Efficiency Revenue Growth Strategic Expansion